These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33965490)

  • 21. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication of carboxymethyl chitosan/poly(ε-caprolactone)/doxorubicin/nickel ferrite core-shell fibers for controlled release of doxorubicin against breast cancer.
    Abasalta M; Asefnejad A; Khorasani MT; Saadatabadi AR
    Carbohydr Polym; 2021 Apr; 257():117631. PubMed ID: 33541657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
    Naruphontjirakul P; Viravaidya-Pasuwat K
    Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis of magnetic chitosan/hyaluronic acid/κ-carrageenan nanocarriers for drug delivery.
    Anbardan MA; Alipour S; Mahdavinia GR; Rezaei PF
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126805. PubMed ID: 37689291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of pH-responsive compounds synthesized from chitosan and hyaluronic acid on dual-responsive (pH/temperature) hydrogel drug delivery systems of Cortex Moutan.
    Chatterjee S; Hui PC; Siu WS; Kan CW; Leung PC; Wanxue C; Chiou JC
    Int J Biol Macromol; 2021 Jan; 168():163-174. PubMed ID: 33309656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer.
    Wang Y; Qian J; Yang M; Xu W; Wang J; Hou G; Ji L; Suo A
    Carbohydr Polym; 2019 Dec; 225():115206. PubMed ID: 31521263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.
    Campos J; Varas-Godoy M; Haidar ZS
    Nanomedicine (Lond); 2017 Mar; 12(5):473-490. PubMed ID: 28181464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
    Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
    Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan chloride for superoxide dismutase delivery.
    Cheng Y; Cai H; Yin B; Yao P
    Int J Pharm; 2013 Sep; 454(1):425-34. PubMed ID: 23830946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application.
    Esfandiarpour-Boroujeni S; Bagheri-Khoulenjani S; Mirzadeh H; Amanpour S
    Carbohydr Polym; 2017 Jul; 168():14-21. PubMed ID: 28457434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.
    Liao T; Liu C; Ren J; Chen H; Kuang Y; Jiang B; Chen J; Sun Z; Li C
    Int J Biol Macromol; 2021 Jul; 183():2017-2029. PubMed ID: 34097958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor.
    Chen H; Fan X; Zhao Y; Zhi D; Cui S; Zhang E; Lan H; Du J; Zhang Z; Zhang S; Zhen Y
    ACS Appl Mater Interfaces; 2020 May; 12(19):22074-22087. PubMed ID: 32083833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radio-frequency triggered heating and drug release using doxorubicin-loaded LSMO nanoparticles for bimodal treatment of breast cancer.
    Kulkarni VM; Bodas D; Dhoble D; Ghormade V; Paknikar K
    Colloids Surf B Biointerfaces; 2016 Sep; 145():878-890. PubMed ID: 27337564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin.
    Termsarasab U; Yoon IS; Park JH; Moon HT; Cho HJ; Kim DD
    Int J Pharm; 2014 Apr; 464(1-2):127-34. PubMed ID: 24451239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of the Antioxidant and Antitumor Activities of Benzimidazole-Chitosan Quaternary Ammonium Salt on Drug Delivery Nanogels.
    Ma B; Li Q; Zhang J; Mi Y; Tan W; Guo Z
    Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38248665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.